|
Dr. Pearlman is the founder and CEO of Medgenics. He has over 25 years experience founding and managing biotechnology and medical device companies, as well as inventing and developing biomedical technology. Prior to founding Medgenics, Dr. Pearlman was founding CEO and chief scientist for TransScan R&D Ltd (now Mirabel Medical Systems), under whose leadership the company's product, the T-scan 2000 breast impedance scanner, was the first new medical imaging method for cancer detection to receive U.S. Food and Drug Administration (FDA) pre-market approval in over 20 years. He has also founded or co-founded several other companies in the fields of diagnosis and patient monitoring.
Dr. Pearlman holds a Ph.D. in biophysics from the University of California, Berkeley, where he completed his doctoral thesis under Nobel Laureates; Professors Melvin Calvin and Donald Glaser. | 